Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
CoreCard Corporation CCRD: This technology solutions and processing services company has seen the Zacks Consensus Estimate for its current year earnings increasing 7% over the last 60 days.
CoreCard Corporation price-consensus-chart | CoreCard Corporation Quote
Appian Corporation APPN: This software company has seen the Zacks Consensus Estimate for its current year earnings increasing 33.3% over the last 60 days.
Appian Corporation price-consensus-chart | Appian Corporation Quote
USANA Health Sciences, Inc. USNA: This nutritional, personal care, and skincare products company has seen the Zacks Consensus Estimate for its next year earnings increasing 12.8% over the last 60 days.
USANA Health Sciences, Inc. price-consensus-chart | USANA Health Sciences, Inc. Quote
Entrada Therapeutics, Inc. TRDA: This clinical-stage biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 64.7% over the last 60 days.
Entrada Therapeutics, Inc. price-consensus-chart | Entrada Therapeutics, Inc. Quote
NRx Pharmaceuticals, Inc. NRXP: This clinical-stage biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 46.2% over the last 60 days.
NRx Pharmaceuticals, Inc. price-consensus-chart | NRx Pharmaceuticals, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
USANA Health Sciences, Inc. (USNA) : Free Stock Analysis Report
Appian Corporation (APPN) : Free Stock Analysis Report
NRx Pharmaceuticals, Inc. (NRXP) : Free Stock Analysis Report
Entrada Therapeutics, Inc. (TRDA) : Free Stock Analysis Report
CoreCard Corporation (CCRD) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.